REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN)
CUSIP: 75886F107
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 104,986,330
- Total 13F shares
- 94,041,724
- Share change
- +1,215,395
- Total reported value
- $98,807,158,234
- Put/Call ratio
- 143%
- Price per share
- $1051.03
- Number of holders
- 1,326
- Value change
- +$1,312,660,088
- Number of buys
- 647
- Number of sells
- 511
Quarterly Holders Quick Answers
What is CUSIP 75886F107?
CUSIP 75886F107 identifies REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 75886F107:
Top shareholders of REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
10%
|
10,794,072
|
$10,389,186,194 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.5%
|
8,930,241
|
$8,595,267,661 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
8.2%
|
8,568,654
|
$8,247,244,169 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
7.4%
|
7,727,174
|
$7,437,328,032 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
4.6%
|
4,841,548
|
$4,659,941,535 | — | 31 Mar 2024 | |
| Capital World Investors |
13F
|
Company |
4.4%
|
4,654,855
|
$4,480,251,527 | — | 31 Mar 2024 | |
| Capital International Investors |
13F
|
Company |
3%
|
3,129,010
|
$3,011,640,075 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
2,376,591
|
$2,282,279,346 | — | 31 Mar 2024 | |
| DODGE & COX |
13F
|
Company |
2.2%
|
2,359,864
|
$2,271,345,501 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.6%
|
1,694,298
|
$1,630,744,885 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.3%
|
1,339,499
|
$1,289,256,381 | — | 31 Mar 2024 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1.1%
|
1,207,195
|
$1,161,914,000 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
1.1%
|
1,104,274
|
$1,062,852,682 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1%
|
1,092,975
|
$1,051,977,508 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.94%
|
991,465
|
$954,275,149 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.94%
|
986,068
|
$949,080,589 | — | 31 Mar 2024 | |
| Amundi |
13F
|
Individual |
1%
|
1,056,459
|
$944,634,427 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.86%
|
902,613
|
$868,757,000 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.84%
|
886,544
|
$853,289,940 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.84%
|
884,068
|
$850,906,369 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.84%
|
881,905
|
$848,825,688 | — | 31 Mar 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.78%
|
819,282
|
$788,549,345 | — | 31 Mar 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.7%
|
736,533
|
$708,905,647 | — | 31 Mar 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.65%
|
684,564
|
$658,886,004 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.61%
|
638,223
|
$614,283,531 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.56%
|
588,953
|
$566,861,170 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.51%
|
538,750
|
$518,541,488 | — | 31 Mar 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.46%
|
480,524
|
$462,499,544 | — | 31 Mar 2024 | |
| VAGELOS P ROY |
3/4/5
|
Director |
—
class O/S missing
|
467,104
|
$444,337,350 | — | 03 Apr 2023 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.43%
|
451,684
|
$434,741,742 | — | 31 Mar 2024 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.39%
|
407,058
|
$391,789,254 | — | 31 Mar 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.39%
|
404,244
|
$389,572,599 | — | 31 Mar 2024 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.38%
|
404,008
|
$388,854,000 | — | 31 Mar 2024 | |
| Capital Research Global Investors |
13F
|
Company |
0.38%
|
394,182
|
$379,396,233 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.36%
|
380,921
|
$366,632,456 | — | 31 Mar 2024 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.36%
|
377,426
|
$363,168,170 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.33%
|
343,618
|
$330,728,886 | — | 31 Mar 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.32%
|
338,296
|
$325,605,841 | — | 31 Mar 2024 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.32%
|
336,472
|
$323,851,009 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.32%
|
332,545
|
$319,958,114 | — | 31 Mar 2024 | |
| Swiss National Bank |
13F
|
Company |
0.31%
|
320,800
|
$308,766,792 | — | 31 Mar 2024 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.3%
|
319,048
|
$307,080,510 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.3%
|
312,076
|
$300,370,029 | — | 31 Mar 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.26%
|
269,511
|
$259,401,642 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.25%
|
257,481
|
$247,822,888 | — | 31 Mar 2024 | |
| Chevy Chase Trust Holdings, LLC |
13F
|
Company |
0.23%
|
242,380
|
$233,288,327 | — | 31 Mar 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.23%
|
239,824
|
$230,828,202 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.22%
|
230,471
|
$221,826,033 | — | 31 Mar 2024 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.22%
|
229,053
|
$221,537,771 | — | 31 Mar 2024 | |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC |
13F
|
Individual |
0.22%
|
228,001
|
$219,448,681 | — | 31 Mar 2024 |
Institutional Holders of REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN) as of Q2 2024
As of 30 Jun 2024,
REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN) was held by
1,326 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
94,041,724 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock Inc., JPMORGAN CHASE & CO, STATE STREET CORP, Capital World Investors, Capital International Investors, GEODE CAPITAL MANAGEMENT, LLC, Dodge & Cox, and FRANKLIN RESOURCES INC.
This page lists
1,328
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
1,301
Q2 2024 holders
1,326
Holder diff
25
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.